Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
Inhibition of actin polymerization enhances commitment to and execution of apoptosis induced by withdrawal of trophic support.
Authors: Authors: Celeste Morley S, Sun GP, Bierer BE.
J Cell Biochem
View full abstract on Pubmed
Differential chemokine expression profiles in human peripheral blood T lymphocytes: dependence on T-cell coreceptor and calcineurin signaling.
Authors: Authors: Cristillo AD, Macri MJ, Bierer BE.
Blood
View full abstract on Pubmed
Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expression.
Authors: Authors: Cristillo AD, Xiao X, Campbell-Malone R, Dimitrov DS, Bierer BE.
Exp Mol Pathol
View full abstract on Pubmed
Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element.
Authors: Authors: Cristillo AD, Highbarger HC, Dewar RL, Dimitrov DS, Golding H, Bierer BE.
FASEB J
View full abstract on Pubmed
Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis.
Authors: Authors: Cristillo AD, Bierer BE.
J Biol Chem
View full abstract on Pubmed
Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin.
Authors: Authors: Li TK, Baksh S, Cristillo AD, Bierer BE.
J Cell Biochem
View full abstract on Pubmed
T cell regulation of p62(dok) (Dok1) association with Crk-L.
Authors: Authors: Martelli MP, Boomer J, Bu M, Bierer BE.
J Biol Chem
View full abstract on Pubmed
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Authors: Authors: Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.
Bone Marrow Transplant
View full abstract on Pubmed
T-lymphocyte coactivator molecules.
Authors: Authors: Salazar-Fontana LI, Bierer BE.
Curr Opin Hematol
View full abstract on Pubmed
T cell signal transduction and the role of CD7 in costimulation.
Authors: Authors: Stillwell R, Bierer BE.
Immunol Res
View full abstract on Pubmed